Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-12-31 Purchase |
2022-01-04 08:51 am |
REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO and CFO |
16,000 | $26.22 | $419,565 | 19,000 (Direct) |
View |
2021-06-14 Sale |
2021-06-16 4:04 pm |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer |
60,000 | $142.58 | $8,554,906 | 532,419 (Direct) |
View |
2021-06-07 Sale |
2021-06-09 4:28 pm |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
10,000 | $142.65 | $1,426,513 | 52,868 (Direct) |
View |
2021-05-26 Sale |
2021-05-27 6:15 pm |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
10,000 | $124.55 | $1,245,470 | 47,414 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-01-03 Option Award |
2023-01-04 4:48 pm |
N/A 2033-01-03 |
REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer |
59,494 | $0 | 94,643 (Direct) |
View |
2023-01-03 Option Award |
2023-01-04 4:11 pm |
N/A 2033-01-03 |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
79,325 | $0 | 114,325 (Direct) |
View |
2023-01-03 Option Award |
2023-01-04 4:07 pm |
N/A 2033-01-03 |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar VP, Chief Accounting Officer |
41,750 | $0 | 58,250 (Direct) |
View |
2022-07-11 Option Award |
2022-07-12 4:26 pm |
N/A 2032-07-11 |
REATA PHARMACEUTICALS INC | RETA | Ryder Steven Director |
11,530 | $0 | 21,730 (Direct) |
View |
2022-07-11 Option Award |
2022-07-12 4:26 pm |
N/A 2032-07-11 |
REATA PHARMACEUTICALS INC | RETA | Ryder Steven Director |
1,322 | $22.36 | 21,730 (Direct) |
View |
2022-07-11 Option Award |
2022-07-12 4:26 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ryder Steven Director |
8,878 | $32.36 | 21,730 (Direct) |
View |
2022-06-08 Option Award |
2022-06-10 6:33 pm |
N/A 2032-06-08 |
REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director 10% Owner |
11,240 | $0 | 16,027 (Direct) |
View |
2022-06-08 Option Award |
2022-06-10 6:33 pm |
N/A 2032-06-08 |
REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director 10% Owner |
4,787 | $24.02 | 16,027 (Direct) |
View |
2022-06-08 Option Award |
2022-06-10 4:30 pm |
N/A 2032-06-08 |
REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Member of 10% owner group Director 10% Owner |
11,240 | $0 | 14,570 (Direct) |
View |
2022-06-08 Option Award |
2022-06-10 4:30 pm |
N/A 2032-06-08 |
REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Member of 10% owner group Director 10% Owner |
3,330 | $24.02 | 14,570 (Direct) |
View |
2022-06-08 Option Award |
2022-06-09 4:47 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director |
5,105 | $34.76 | 12,612 (Direct) |
View |
2022-06-08 Option Award |
2022-06-09 4:47 pm |
N/A 2032-06-08 |
REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director |
5,620 | $0 | 12,612 (Direct) |
View |
2022-06-08 Option Award |
2022-06-09 4:47 pm |
N/A 2032-06-08 |
REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director |
1,769 | $24.02 | 12,612 (Direct) |
View |
2022-06-08 Option Award |
2022-06-09 4:42 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Oliger Christy J. Director |
3,883 | $34.76 | 9,503 (Direct) |
View |
2022-06-08 Option Award |
2022-06-09 4:42 pm |
N/A 2032-06-08 |
REATA PHARMACEUTICALS INC | RETA | Oliger Christy J. Director |
5,620 | $0 | 9,503 (Direct) |
View |
2022-06-08 Option Award |
2022-06-09 4:37 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
4,170 | $34.76 | 10,265 (Direct) |
View |
2022-06-08 Option Award |
2022-06-09 4:37 pm |
N/A 2032-06-08 |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
5,620 | $0 | 10,265 (Direct) |
View |
2022-06-08 Option Award |
2022-06-09 4:37 pm |
N/A 2032-06-08 |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
416 | $24.02 | 10,265 (Direct) |
View |
2022-06-08 Option Award |
2022-06-09 4:20 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Edwards Martin Director |
4,242 | $34.76 | 10,441 (Direct) |
View |
2022-06-08 Option Award |
2022-06-09 4:20 pm |
N/A 2032-06-08 |
REATA PHARMACEUTICALS INC | RETA | Edwards Martin Director |
5,620 | $0 | 10,441 (Direct) |
View |
2022-06-08 Option Award |
2022-06-09 4:20 pm |
N/A 2032-06-08 |
REATA PHARMACEUTICALS INC | RETA | Edwards Martin Director |
520 | $24.02 | 10,441 (Direct) |
View |
Ownership |
2022-02-07 4:18 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Loewen Andrea SVP, Global Regulatory Affairs |
0 | $0 | 103,106 (Direct) |
View |
Ownership |
2022-02-07 4:11 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer |
0 | $0 | 115,249 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 5:22 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director 10% Owner |
399 | $16.14 | 399 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 4:10 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar VP, Chief Accounting Officer |
37,500 | $0 | 41,500 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 4:09 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
105,000 | $0 | 105,000 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 4:08 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer |
105,000 | $0 | 122,000 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 4:07 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO and CFO |
150,000 | $0 | 169,000 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 4:06 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
105,000 | $0 | 105,000 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 4:04 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director |
118 | $27.32 | 317 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 4:04 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director |
199 | $16.14 | 317 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 4:03 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
59 | $27.32 | 158 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 4:03 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
99 | $16.14 | 158 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 4:02 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Edwards Martin Director |
59 | $27.32 | 158 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 4:02 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | Edwards Martin Director |
99 | $16.14 | 158 (Direct) |
View |
Ownership |
2021-11-15 10:16 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar VP, Chief Accounting Officer |
0 | $0 | 19,000 (Direct) |
View |
2021-06-16 Exercise |
2021-06-16 4:04 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer |
19,525 | $11.62 | 532,419 (Direct) |
View |
2021-06-16 Exercise |
2021-06-16 4:04 pm |
N/A 2023-06-15 |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer |
19,525 | $0 | 532,419 (Direct) |
View |
2021-06-14 Conversion |
2021-06-16 4:04 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer |
5,000 | $0 | 532,419 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 5:25 pm |
N/A 2031-06-10 |
REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director 10% Owner |
5,000 | $0 | 5,690 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 5:25 pm |
N/A 2031-06-10 |
REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director 10% Owner |
690 | $83.24 | 5,690 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:11 pm |
N/A 2031-06-10 |
REATA PHARMACEUTICALS INC | RETA | Edwards Martin Director |
5,000 | $0 | 5,000 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:05 pm |
N/A 2031-06-10 |
REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Member of 10% owner group Director 10% Owner |
5,000 | $0 | 5,810 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:05 pm |
N/A 2031-06-10 |
REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Member of 10% owner group Director 10% Owner |
810 | $83.24 | 5,810 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 11:33 am |
N/A 2031-06-10 |
REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director |
5,000 | $0 | 5,780 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 11:33 am |
N/A 2031-06-10 |
REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director |
780 | $83.24 | 5,780 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 11:29 am |
N/A 2031-06-10 |
REATA PHARMACEUTICALS INC | RETA | Oliger Christy J. Director |
5,000 | $0 | 5,180 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 11:29 am |
N/A 2031-06-10 |
REATA PHARMACEUTICALS INC | RETA | Oliger Christy J. Director |
180 | $83.24 | 5,180 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 11:26 am |
N/A 2031-06-10 |
REATA PHARMACEUTICALS INC | RETA | Nielsen Jack Director |
5,000 | $0 | 6,201 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 11:26 am |
N/A 2031-06-10 |
REATA PHARMACEUTICALS INC | RETA | Nielsen Jack Director |
1,201 | $83.24 | 6,201 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 11:21 am |
N/A 2031-06-10 |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
5,000 | $0 | 5,000 (Direct) |
View |
2021-06-07 Exercise |
2021-06-09 4:28 pm |
N/A 2026-12-07 |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
10,000 | $0 | 52,868 (Direct) |
View |
2021-06-07 Exercise |
2021-06-09 4:28 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
10,000 | $22.57 | 52,868 (Direct) |
View |
2021-06-07 Conversion |
2021-06-09 4:28 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
10,000 | $0 | 52,868 (Direct) |
View |
2021-05-26 Exercise |
2021-05-27 6:15 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
2,934 | $11 | 47,414 (Direct) |
View |
2021-05-26 Exercise |
2021-05-27 6:15 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
10,000 | $0 | 47,414 (Direct) |
View |
2021-05-26 Exercise |
2021-05-27 6:15 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
7,066 | $22.57 | 47,414 (Direct) |
View |
2021-05-26 Conversion |
2021-05-27 6:15 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
10,000 | $0 | 47,414 (Direct) |
View |
2021-04-15 Option Award |
2021-04-16 1:38 pm |
N/A 2031-04-15 |
REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director |
319 | $52.85 | 11,569 (Direct) |
View |
2021-04-15 Option Award |
2021-04-16 1:38 pm |
N/A 2031-04-15 |
REATA PHARMACEUTICALS INC | RETA | Ruff Shamim Director |
11,250 | $0 | 11,569 (Direct) |
View |
2021-04-15 Option Award |
2021-04-16 1:34 pm |
N/A 2031-04-15 |
REATA PHARMACEUTICALS INC | RETA | Oliger Christy J. Director |
106 | $52.85 | 11,356 (Direct) |
View |
2021-04-15 Option Award |
2021-04-16 1:34 pm |
N/A 2031-04-15 |
REATA PHARMACEUTICALS INC | RETA | Oliger Christy J. Director |
11,250 | $0 | 11,356 (Direct) |
View |
2020-12-22 Ownership |
2021-01-06 5:14 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer |
270,000 | $0 | 2,036,748 (Direct) |
View |
Ownership |
2021-01-06 5:14 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer |
0 | $0 | 2,036,748 (Indirect) |
View |
2021-01-04 Option Award |
2021-01-06 4:52 pm |
N/A 2031-01-04 |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
16,500 | $0 | 16,500 (Direct) |
View |